1370 related articles for article (PubMed ID: 24217192)
1. Prevention and treatment of age-related macular degeneration: an update for pharmacists.
Marshall LL; Roach JM
Consult Pharm; 2013 Nov; 28(11):723-37. PubMed ID: 24217192
[TBL] [Abstract][Full Text] [Related]
2. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
Age-Related Eye Disease Study 2 Research Group
JAMA; 2013 May; 309(19):2005-15. PubMed ID: 23644932
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
Evans JR; Lawrenson JG
Cochrane Database Syst Rev; 2023 Sep; 9(9):CD000254. PubMed ID: 37702300
[TBL] [Abstract][Full Text] [Related]
4. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.
; Chew EY; Clemons TE; Sangiovanni JP; Danis RP; Ferris FL; Elman MJ; Antoszyk AN; Ruby AJ; Orth D; Bressler SB; Fish GE; Hubbard GB; Klein ML; Chandra SR; Blodi BA; Domalpally A; Friberg T; Wong WT; Rosenfeld PJ; Agrón E; Toth CA; Bernstein PS; Sperduto RD
JAMA Ophthalmol; 2014 Feb; 132(2):142-9. PubMed ID: 24310343
[TBL] [Abstract][Full Text] [Related]
5. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28.
Chew EY; Clemons TE; Agrón E; Domalpally A; Keenan TDL; Vitale S; Weber C; Smith DC; Christen W;
JAMA Ophthalmol; 2022 Jul; 140(7):692-698. PubMed ID: 35653117
[TBL] [Abstract][Full Text] [Related]
6. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).
; Chew EY; Clemons T; SanGiovanni JP; Danis R; Domalpally A; McBee W; Sperduto R; Ferris FL
Ophthalmology; 2012 Nov; 119(11):2282-9. PubMed ID: 22840421
[TBL] [Abstract][Full Text] [Related]
7. No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18.
van Asten F; Chiu CY; Agrón E; Clemons TE; Ratnapriya R; Swaroop A; Klein ML; Fan R; Chew EY;
Ophthalmology; 2019 Nov; 126(11):1541-1548. PubMed ID: 31358387
[TBL] [Abstract][Full Text] [Related]
8. Lifestyle modification, nutritional and vitamins supplements for age-related macular degeneration.
Sin HP; Liu DT; Lam DS
Acta Ophthalmol; 2013 Feb; 91(1):6-11. PubMed ID: 22268800
[TBL] [Abstract][Full Text] [Related]
9. Review of nutrient actions on age-related macular degeneration.
Zampatti S; Ricci F; Cusumano A; Marsella LT; Novelli G; Giardina E
Nutr Res; 2014 Feb; 34(2):95-105. PubMed ID: 24461310
[TBL] [Abstract][Full Text] [Related]
10. Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
; Bonds DE; Harrington M; Worrall BB; Bertoni AG; Eaton CB; Hsia J; Robinson J; Clemons TE; Fine LJ; Chew EY
JAMA Intern Med; 2014 May; 174(5):763-71. PubMed ID: 24638908
[TBL] [Abstract][Full Text] [Related]
11. Nutritional supplements for age-related macular degeneration.
Krishnadev N; Meleth AD; Chew EY
Curr Opin Ophthalmol; 2010 May; 21(3):184-9. PubMed ID: 20216418
[TBL] [Abstract][Full Text] [Related]
12. Age-related macular degeneration.
Cheung LK; Eaton A
Pharmacotherapy; 2013 Aug; 33(8):838-55. PubMed ID: 23580402
[TBL] [Abstract][Full Text] [Related]
13. Nutritional supplements in age-related macular degeneration.
Schmidl D; Garhöfer G; Schmetterer L
Acta Ophthalmol; 2015 Mar; 93(2):105-21. PubMed ID: 25586104
[TBL] [Abstract][Full Text] [Related]
14. [Macular pigment and age-related macular degeneration. Clinical implications].
Haddad WM; Souied E; Coscas G; Soubrane G
Bull Soc Belge Ophtalmol; 2006; (301):15-22. PubMed ID: 17552428
[TBL] [Abstract][Full Text] [Related]
15. Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36.
Chew EY; Clemons TE; Agrón E; Sperduto RD; Sangiovanni JP; Davis MD; Ferris FL;
JAMA Ophthalmol; 2014 Mar; 132(3):272-7. PubMed ID: 24385141
[TBL] [Abstract][Full Text] [Related]
16. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.
Age-Related Eye Disease Study Research Group
Arch Ophthalmol; 2001 Oct; 119(10):1417-36. PubMed ID: 11594942
[TBL] [Abstract][Full Text] [Related]
17. Dietary Nutrient Intake and Progression to Late Age-Related Macular Degeneration in the Age-Related Eye Disease Studies 1 and 2.
Agrón E; Mares J; Clemons TE; Swaroop A; Chew EY; Keenan TDL;
Ophthalmology; 2021 Mar; 128(3):425-442. PubMed ID: 32858063
[TBL] [Abstract][Full Text] [Related]
18. Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: the Nutritional AMD Treatment 2 study.
Souied EH; Delcourt C; Querques G; Bassols A; Merle B; Zourdani A; Smith T; Benlian P;
Ophthalmology; 2013 Aug; 120(8):1619-31. PubMed ID: 23395546
[TBL] [Abstract][Full Text] [Related]
19. An eye on nutrition: The role of vitamins, essential fatty acids, and antioxidants in age-related macular degeneration, dry eye syndrome, and cataract.
McCusker MM; Durrani K; Payette MJ; Suchecki J
Clin Dermatol; 2016; 34(2):276-85. PubMed ID: 26903189
[TBL] [Abstract][Full Text] [Related]
20. Adherence to recommendations of the age-related eye disease study in patients with age-related macular degeneration.
Hochstetler BS; Scott IU; Kunselman AR; Thompson K; Zerfoss E
Retina; 2010 Sep; 30(8):1166-70. PubMed ID: 20827137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
